Jeer Medicolegal Reporting Limited 07969670 false 2023-04-01 2024-03-31 2024-03-31 The principal activity of the company is Medical Report Services. Digita Accounts Production Advanced 6.30.9574.0 true 07969670 2023-04-01 2024-03-31 07969670 2024-03-31 07969670 core:CurrentFinancialInstruments 2024-03-31 07969670 core:CurrentFinancialInstruments core:WithinOneYear 2024-03-31 07969670 core:Non-currentFinancialInstruments core:AfterOneYear 2024-03-31 07969670 core:FurnitureFittingsToolsEquipment 2024-03-31 07969670 core:MotorVehicles 2024-03-31 07969670 bus:SmallEntities 2023-04-01 2024-03-31 07969670 bus:AuditExemptWithAccountantsReport 2023-04-01 2024-03-31 07969670 bus:FilletedAccounts 2023-04-01 2024-03-31 07969670 bus:SmallCompaniesRegimeForAccounts 2023-04-01 2024-03-31 07969670 bus:RegisteredOffice 2023-04-01 2024-03-31 07969670 bus:Director1 2023-04-01 2024-03-31 07969670 bus:Director2 2023-04-01 2024-03-31 07969670 bus:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 07969670 core:FurnitureFittingsToolsEquipment 2023-04-01 2024-03-31 07969670 core:MotorVehicles 2023-04-01 2024-03-31 07969670 countries:England 2023-04-01 2024-03-31 07969670 2023-03-31 07969670 core:FurnitureFittingsToolsEquipment 2023-03-31 07969670 core:MotorVehicles 2023-03-31 07969670 2022-04-01 2023-03-31 07969670 2023-03-31 07969670 core:CurrentFinancialInstruments 2023-03-31 07969670 core:CurrentFinancialInstruments core:WithinOneYear 2023-03-31 07969670 core:Non-currentFinancialInstruments core:AfterOneYear 2023-03-31 07969670 core:FurnitureFittingsToolsEquipment 2023-03-31 07969670 core:MotorVehicles 2023-03-31 iso4217:GBP xbrli:pure

Registration number: 07969670

Jeer Medicolegal Reporting Limited

Unaudited Filleted Abridged Financial Statements

for the Year Ended 31 March 2024

 

Jeer Medicolegal Reporting Limited

Contents

Company Information

1

Abridged Balance Sheet

2 to 3

Notes to the Unaudited Abridged Financial Statements

4 to 8

 

Jeer Medicolegal Reporting Limited

Company Information

Directors

Dr P Jeer

Mrs H Jeer

Registered office

26 High Street
Rickmansworth
Hertfordshire
WD3 1ER

 

Jeer Medicolegal Reporting Limited

(Registration number: 07969670)
Abridged Balance Sheet as at 31 March 2024

Note

2024
£

2023
£

Fixed assets

 

Tangible assets

4

76,400

101,787

Investment property

156,820

156,820

 

233,220

258,607

Current assets

 

Debtors

5

141,597

145,434

Cash at bank and in hand

 

32,226

59,069

 

173,823

204,503

Creditors: Amounts falling due within one year

(43,862)

(49,489)

Net current assets

 

129,961

155,014

Total assets less current liabilities

 

363,181

413,621

Creditors: Amounts falling due after more than one year

(35,903)

(63,493)

Provisions for liabilities

(11,405)

(16,030)

Accruals and deferred income

 

(3,472)

(4,413)

Net assets

 

312,401

329,685

Capital and reserves

 

Called up share capital

6

100

100

Retained earnings

312,301

329,585

Shareholders' funds

 

312,401

329,685

For the financial year ending 31 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

All of the company’s members have consented to the preparation of an Abridged Balance Sheet in accordance with Section 444(2A) of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

 

Jeer Medicolegal Reporting Limited

(Registration number: 07969670)
Abridged Balance Sheet as at 31 March 2024

Approved and authorised by the Board on 19 March 2025 and signed on its behalf by:
 

.........................................
Dr P Jeer
Director

 

Jeer Medicolegal Reporting Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 March 2024

1

General information

The company is a private company limited by share capital, incorporated in England.

The address of its registered office is:
26 High Street
Rickmansworth
Hertfordshire
WD3 1ER

These financial statements were authorised for issue by the Board on 19 March 2025.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These abridged financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These abridged financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

 

Jeer Medicolegal Reporting Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 March 2024

Deferred tax is recognised in respect of all timing differences between taxable profits and profits reported in the financial statements.

Unrelieved tax losses and other deferred tax assets are recognised when it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Motor vehicle

25% straight line basis

Leases

Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessee.

Assets held under finance leases are recognised at the lower of their fair value at inception of the lease and the present value of the minimum lease payments. These assets are depreciated on a straight-line basis over the shorter of the useful life of the asset and the lease term. The corresponding liability to the lessor is included in the balance sheet as a finance lease obligation.

Lease payments are apportioned between finance costs in the profit and loss account and reduction of the lease obligation so as to achieve a constant periodic rate of interest on the remaining balance of the liability.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 4 (2023 - 2).

 

Jeer Medicolegal Reporting Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 March 2024

4

Tangible assets

Furniture, fittings and equipment
 £

Motor vehicles
 £

Total
£

Cost or valuation

At 1 April 2023

240

118,884

119,124

At 31 March 2024

240

118,884

119,124

Depreciation

At 1 April 2023

-

17,337

17,337

Charge for the year

-

25,387

25,387

At 31 March 2024

-

42,724

42,724

Carrying amount

At 31 March 2024

240

76,160

76,400

At 31 March 2023

240

101,547

101,787

5

Debtors

Debtors includes £Nil (2023 - £Nil) due after more than one year.

6

Share capital

Allotted, called up and fully paid shares

2024

2023

No.

£

No.

£

Ordinary of £1 each

100

100

100

100

       

7

Dividends

2024

2023

£

£

Interim dividend of £450.00 (2023 - £100.00) per ordinary share

45,000

10,000

 

 
 

Jeer Medicolegal Reporting Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 March 2024

8

Related party transactions

During the year, the Company paid interim dividends of £45,000 (2023 - £10,000) to the directors of the company.

At 31 March 2024, the balance owing from Jeer Estates limited was £130,000 (2023 - £130,000). Jeer Estates Limited is a company with common directors.

 

Jeer Medicolegal Reporting Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 March 2024

Directors' remuneration

The directors' remuneration for the year was as follows:

2024
£

2023
£

Remuneration

7,920

7,920